Tumor mice model market is witnessing sustained growth as oncology research intensifies and pharmaceutical companies seek more predictive preclinical platforms. Valued at USD 1.82 billion in 2024, the market is projected to reach USD 2.92 billion by 2031, expanding at a compound annual growth rate (CAGR) of 7.1% during the forecast period from 2025 to 2032.
Discover Market Highlights...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek